Key result
SARS-CoV2 infection in a 71-year-old woman was associated with median Takotsubo syndrome, highlighting the importance of differential diagnosis for troponin elevation in COVID-19 patients.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
This case highlights Takotsubo syndrome as a potential cause of troponin elevation in patients with COVID-19.
A 71-year-old woman was admitted to our hospital after fainting. Her past medical history included arterial hypertension, hypercholesterolaemia, and normotensive hydrocephalus treated with a ventriculoperitoneal shunt. She was taking amlodipine and rosuvastatin. She was dyspnoeic at rest, afebrile, with a heart rate of 75 b.p.m. and a blood pressure of 119/76 mmHg. Hypoxaemia was present (PaO2 of 56 mmHg) despite a 100% O2 non-rebreathing mask. The patient was put on mechanical ventilation. Contrast-enhanced brain CT was negative. The chest CT showed ground glass opacity involving 10–20% of the lungs (Panel A). Blood tests showed elevated troponin T (412.7 ng/L, normal <14). The ECG showed sinus rhythm with prolonged QT interval (QTc 521 ms) (Panel B). The nasopharyngeal swab PCR test was positive for a SARS-CoV2 infection. The patient underwent a coronary angiogram showing significant lesions on the proximal LAD and the first diagonal arteries. Two drug-eluting stents were successfully placed. The ventriculogram showed regional wall motion abnormality unrelated to the coronary lesions, compatible with a median Takotsubo. (Panels C and D; Supplementary material online, Video 1). To our knowledge, this is the first description of median Takotsubo syndrome in a patient with COVID-19. This case stresses the importance of the differential diagnosis of troponin elevation as other causes such as Takotsubo syndrome might be found in SARS-Cov2 infection. Conflict of interest: none declared. Supplementary material is available online at European Heart Journal – Cardiovascular Imaging.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2020) conducted a case report in Takotsubo cardiomyopathy with COVID-19 (n=1). SARS-CoV2 infection was evaluated. SARS-CoV2 infection in a 71-year-old woman was associated with median Takotsubo syndrome, highlighting the importance of differential diagnosis for troponin elevation in COVID-19 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: